Adebelimab

DRUG2 trials

Sponsors

Peking Union Medical College Hospital, Fudan University

Conditions

Brain MetastasasesRecurrent/Metastatic Endometrial CancerTNBC, Triple Negative Breast Cancer

Phase 2

Adebrelimab Plus Carboplatin/Paclitaxel Followed by Adebelizumab with or Without Apatinib in the Treatment of Advanced Recurrent/Metastatic Endometrial Cancer (A-CAPE): a Multicenter, Randomized, Controlled, Open-Label Clinical Trial

Not yet recruitingNCT06771154

Peking Union Medical College HospitalRecurrent/Metastatic Endometrial Cancer

Start: 2025-04-01End: 2029-04-01Target: 140Updated: 2025-01-13

Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

RecruitingNCT07638852

Fudan UniversityTNBC, Triple Negative Breast Cancer, Brain Metastasases

Start: 2026-02-02End: 2028-12-31Target: 58Updated: 2026-09-10